Category Archives: Diabetes Medication

Warning Letters Issued to Illegally Sold Diabetes Treatments

Recently, FDA launched an initiative to counter these illegally sold products aimed at consumers who have diabetes. In addition to evaluating numerous consumer complaints, FDA surveyed the marketplace for illegally sold products promising to treat diabetes and its complications.

In …

Illegally Sold Diabetes Treatments Are A Far-Reaching Problem

There are 26 million people in the U.S. who have diabetes, including about 7 million who are undiagnosed, according to the Centers for Disease Control and Prevention. Millions more have pre-diabetes, meaning they have higher than normal blood sugar …

Treating Gestational Diabetes With Medication

According to the results of a new study, toddlers born to moms who develop gestational diabetes that requires medication are 22 percent more likely to be diagnosed with autism.

Researchers say the California-based study doesn’t offer enough information to draw

New Pen Needle Offers Innovative Design

One of the leading manufacturers of diabetes supplies has released a new pen needle designed to make injecting diabetes drugs a less distressing experience, potentially boosting drug compliance.

For many people, it’s difficult to overcome the anxiety associated with injections. …

When Given Control Over Monitoring And Medication, High-Risk Patients Are Able To Lower Their Blood Pressure

A new study finds that patients with hypertension who are given control over monitoring their blood pressure as well as making adjustments to their medications are better able to lower their systolic blood pressure than those who use convention treatment.…

Type 2 Drug Slashes Dementia Risk

A new study has surprising implications for a generic diabetes drug. Pioglitazone, which is often prescribed for patients with Type 2 diabetes, also appears to reduce the risk of developing dementia.

The drug was not studied specifically to see if

BI-Lilly Alliance Creates Formidable Drug Development Combine

Pharma giants Boehringer Ingelheim (BI) and Eli Lilly and Company (Lilly) have formed the

BI-Lilly Diabetes Alliance, a joint effort, involving the development of several drugs aimed at treating type 1 and type 2 diabetes patients.

The Alliance recently showed …

FDA Approves New Neuropathy Pain Drug

The US Food and Drug Administration has approved US sales of NUCYNTA® ER (tapentadol), a twice-daily extended-release oral analgesic for the treatment of pain from diabetic peripheral neuropathy. The drug, produced by New Jersey-based Janssen Pharmaceuticals, Inc., provides around-the-clock management …